Ergi3/Ergic-3 (AA 301-383) Antikörper

Produktnummer ABIN1714743

Dieses Anti--Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von in WB, IF (cc), IF (p), ELISA, IHC (fro), IHC (p) und ICC. Geeignet für Human.

Kurzübersicht für Ergi3/Ergic-3 (AA 301-383) Antikörper (ABIN1714743)

Target: Ergi3/Ergic-3

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)

Produktdetails

Bindungsspezifität: AA 301-383

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human ERGI3/ERGIC-3

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Antigendetails

Target: Ergi3/Ergic-3

Hintergrund:

Synonyms: 2310015B14Rik, AV318804, C20orf47, CGI 54, D2Ucla1, dJ477O4.2, DKFZp547A2190, Endoplasmic reticulum Golgi intermediate compartment protein 3, endoplasmic reticulum localized protein ERp43, Endoplasmic reticulum-Golgi intermediate compartment protein 3, ERGI3_HUMAN, ERGIC and golgi 3, ergic3, ERV46, NY BR 84, PRO0989, RP23-220D12.2, RP3-477O4.1, SDBCAG84, serologically defined breast cancer antigen 84, Serologically defined breast cancer antigen NY BR 84, Serologically defined breast cancer antigen NY-BR-84.

Background: Cycling proteins play important roles in the organization and function of the early secretory pathway by participating in membrane traffic and selective transport of cargo between the endoplasmic reticulum (ER), the intermediate compartment (ERGIC), and the Golgi. A family of membrane bound, ubiquitous proteins involved in the selective transport of newly synthesized glycoproteins from the ER to the ERGIC include VIP36, ERGIC-53, ERGIC-1, ERGIC-2 and ERGIC-3. ERGIC-1, also designated ERGIC32, is thought to modulate the activity of a complex formed by ERGIC-2, also designated Erv41, and ERGIC-3, also designated Erv46. ERGIC-2 and ERGIC-3 are both mammalian homologs of yeast proteins abundant in COPII-coated vesicles and localize to the Cis-face of the Golgi apparatus.

Gen-ID: 51614